ASO Author Reflections: Postoperative Carbohydrate Antigen 19-9 Levels Become a Reliable Biomarker for Establishing Intensity-Stratified Adjuvant Treatments in Pancreatic Ductal Adenocarcinoma
Ann Surg Oncol
.
2024 Jan;31(1):548-549.
doi: 10.1245/s10434-023-14506-z.
Epub 2023 Oct 31.
Authors
Kyohei Ariake
1
,
Takaho Okada
2
,
Haruyuki Tsuchiya
2
,
Daiki Kuboki
2
,
Kimiya Maemura
2
,
Hidetaka Ichikawa
2
,
Tomoyoshi Tachibana
2
,
Naoya Akazawa
2
,
Tomoya Abe
2
,
Tetsuya Kakita
2
,
Masaya Oikawa
2
,
Takashi Tsuchiya
2
Affiliations
1
Department of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, Sendai, Japan. ariake@openhp.or.jp.
2
Department of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, Sendai, Japan.
PMID:
37907696
DOI:
10.1245/s10434-023-14506-z
No abstract available
Publication types
Comment
MeSH terms
Biomarkers
Carbohydrates
Carcinoma, Pancreatic Ductal* / pathology
Carcinoma, Pancreatic Ductal* / surgery
Humans
Pancreatic Neoplasms* / pathology
Pancreatic Neoplasms* / surgery
Substances
Biomarkers
Carbohydrates